Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Asbestos cancer breakthrough

14.11.2003


First-ever blood test for mesothelioma being developed



Researchers at the Pacific Northwest Research Institute (PNRI) have reported the development of a blood test for mesothelioma, a highly aggressive lung cancer caused by asbestos exposure.

A PNRI team led by Dr. Ingegerd Hellstrom, and an Australian team, led by Dr. Bruce Robinson, of the University of Western Australia, conducted the research, which appears in the November 15th issue of Lancet. The new test promises a simple technique for diagnosing and monitoring mesothelioma early in its progress, when therapy is more likely to be successful. Fujirebio Diagnostics, Inc. (FDI) of Malvern, PA, a leading oncology diagnostic company, has acquired an exclusive license from PNRI to develop a commercial test for worldwide distribution.


According to Hellstrom, mesothelioma cells release distinctive molecular markers, SMR (soluble mesothelin-related proteins), into the blood stream. Hellstrom and her colleagues have identified this group of markers and have developed a test to detect them with great specificity.

In blood samples gathered from 273 individuals, researchers found that 84% of those with mesothelioma exhibited high levels of SMR. Only 1.9% of those with other forms of cancer or lung disease had any increased SMR, and patients who were healthy and had not been exposed to asbestos showed no biomarker increase.

"This is a very important breakthrough in the diagnosis and treatment of mesothelioma," Hellstrom explains. "Currently, no blood test exists to detect this cancer and the new biomarker will help doctors see the disease that so far has required much more complicated and expensive tests, and that even then has often gone undetected."

Fujirebio is in the process of initiating the clinical development and commercialization of the mesothelioma test. Dr. Daniel O’Shannessy, FDI’s Chief Scientific Officer, says that this new assay "will provide, for the very first time, a highly effective way of tracking disease progression through noninvasive means."

According to Robinson, from whose patients in Australia the blood samples were drawn, the new research also shows that SMR can be elevated in serum up to several years before actual diagnosis of mesothelioma. "The test may thus prove helpful," Robinson says, "for screening asbestos-exposed individuals for early evidence of mesothelioma."


###
Pacific Northwest Research Institute (PNRI) is a private non-profit biomedical and clinical research laboratory in Seattle, focusing on the prevention and cure of diabetes and cancer. PNRI conducts research in tumor immunology, autoimmune disease, growth factor and metabolic signal transduction pathways, oxidative stress, and large-population screening for diabetes and cancer. The Institute is also participating in a pancreatic islet transplantation research program to treat patients with diabetes. Major emphases of the Hellstrom laboratory at PNRI are on early detection of ovarian, breast, and lung cancers and the development of vaccines for therapeutic purposes. For more information, see www.pnri.org.

Fujirebio Diagnostics, Inc. (FDI), is a premier diagnostics company and the industry leader in Tumor Marker assays specializing in the clinical development, manufacturing and commercialization of in vitro diagnostic products for the management of human disease states with an emphasis in Oncology. The company, formerly known as Centocor Diagnostics, was acquired by Fujirebio, Inc. of Tokyo, Japan in November 1998. FDI utilizes its worldwide distribution network to enable access by physicians and patients to its diagnostic products. For more information on Fujirebio group, visit www.fdi.com.

Contacts:
For PNRI: Rich Murphy
Director of Community Relations, PNRI
206-568-1484
rmurphy@pnri.org

For Fujirebio Diagnostics, Inc.:
Jonathan Morein/Gary Gatyas
Dudnyk Public Relations
267-532-1290/267-532-1244

Rich Murphy | EurekAlert!
Further information:
http://www.pnri.org/

More articles from Health and Medicine:

nachricht Deep stimulation improves cognitive control by augmenting brain rhythms
04.04.2019 | Picower Institute at MIT

nachricht Black nanoparticles slow the growth of tumors
04.04.2019 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum gas turns supersolid

Researchers led by Francesca Ferlaino from the University of Innsbruck and the Austrian Academy of Sciences report in Physical Review X on the observation of supersolid behavior in dipolar quantum gases of erbium and dysprosium. In the dysprosium gas these properties are unprecedentedly long-lived. This sets the stage for future investigations into the nature of this exotic phase of matter.

Supersolidity is a paradoxical state where the matter is both crystallized and superfluid. Predicted 50 years ago, such a counter-intuitive phase, featuring...

Im Focus: Explosion on Jupiter-sized star 10 times more powerful than ever seen on our sun

A stellar flare 10 times more powerful than anything seen on our sun has burst from an ultracool star almost the same size as Jupiter

  • Coolest and smallest star to produce a superflare found
  • Star is a tenth of the radius of our Sun
  • Researchers led by University of Warwick could only see...

Im Focus: Quantum simulation more stable than expected

A localization phenomenon boosts the accuracy of solving quantum many-body problems with quantum computers which are otherwise challenging for conventional computers. This brings such digital quantum simulation within reach on quantum devices available today.

Quantum computers promise to solve certain computational problems exponentially faster than any classical machine. “A particularly promising application is the...

Im Focus: Largest, fastest array of microscopic 'traffic cops' for optical communications

The technology could revolutionize how information travels through data centers and artificial intelligence networks

Engineers at the University of California, Berkeley have built a new photonic switch that can control the direction of light passing through optical fibers...

Im Focus: A long-distance relationship in femtoseconds

Physicists observe how electron-hole pairs drift apart at ultrafast speed, but still remain strongly bound.

Modern electronics relies on ultrafast charge motion on ever shorter length scales. Physicists from Regensburg and Gothenburg have now succeeded in resolving a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

Fraunhofer FHR at the IEEE Radar Conference 2019 in Boston, USA

09.04.2019 | Event News

 
Latest News

Simple and Fast Method for Radiolabelling Antibodies against Breast Cancer

23.04.2019 | Life Sciences

Quantum gas turns supersolid

23.04.2019 | Physics and Astronomy

New automated biological-sample analysis systems to accelerate disease detection

18.04.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>